Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan.
Brain. 2011 May;134(Pt 5):1387-99. doi: 10.1093/brain/awr069. Epub 2011 Apr 12.
Early onset ataxia with ocular motor apraxia and hypoalbuminaemia/ataxia-oculomotor apraxia 1 is a recessively inherited ataxia caused by mutations in the aprataxin gene. We previously reported that patients with frameshift mutations exhibit a more severe phenotype than those with missense mutations. However, reports on genotype-phenotype correlation in early onset ataxia with ocular motor apraxia and hypoalbuminaemia are controversial. To clarify this issue, we studied 58 patients from 39 Japanese families, including 40 patients homozygous for c.689_690insT and nine patients homozygous or compound heterozygous for p.Pro206Leu or p.Val263Gly mutations who were compared with regard to clinical phenotype. We performed Kaplan-Meier analysis and log-rank tests for the ages of onset of gait disturbance and the inability to walk without assistance. The cumulative rate of gait disturbance was lower among patients with p.Pro206Leu or p.Val263Gly mutations than among those homozygous for the c.689_690insT mutation (P=0.001). The cumulative rate of inability to walk without assistance was higher in patients homozygous for the c.689_690insT mutation than in those with p.Pro206Leu or p.Val263Gly mutations (P=0.004). Using a Cox proportional hazards model, we found that the homozygous c.689_690insT mutation was associated with an increased risk for onset of gait disturbance (adjusted hazard ratio: 6.60) and for the inability to walk without assistance (adjusted hazard ratio: 2.99). All patients homozygous for the c.689_690insT mutation presented ocular motor apraxia at <15 years of age. Approximately half the patients homozygous for the c.689_690insT mutation developed cognitive impairment. In contrast, in the patients with p.Pro206Leu or p.Val263Gly mutations, only ∼50% of the patients exhibited ocular motor apraxia and they never developed cognitive impairment. The stepwise multivariate regression analysis using sex, age and the number of c.689_690insT alleles as independent variables revealed that the number of c.689_690insT alleles was independently and negatively correlated with median motor nerve conduction velocities, ulnar motor nerve conduction velocities and values of serum albumin. In the patient with c.[689_690insT]+[840delT], p.[Pro206Leu]+[Pro206Leu] and p.[Pro206Leu]+[Val263Gly] mutations, aprataxin proteins were not detected by an antibody to the N-terminus of aprataxin. Furthermore Pro206Leu and Val263Gly aprataxin proteins are unstable. However, the amount of the 689_690insT aprataxin messenger RNA was also decreased, resulting in more dramatic reduction in the amount of aprataxin protein from the c.689_690insT allele. In conclusion, patients with early onset ataxia with ocular motor apraxia and hypoalbuminaemia homozygous for the c.689_690insT mutation show a more severe phenotype than those with a p.Pro206Leu or p.Val263Gly mutation.
早发性共济失调伴眼球运动性失用和低白蛋白血症/眼动失用 1 是一种隐性遗传性共济失调,由 aprataxin 基因突变引起。我们之前报道过,具有移码突变的患者比具有错义突变的患者表现出更严重的表型。然而,早发性共济失调伴眼球运动性失用和低白蛋白血症的基因型-表型相关性的报告存在争议。为了澄清这个问题,我们研究了 39 个日本家庭的 58 名患者,包括 40 名纯合 c.689_690insT 突变和 9 名纯合或复合杂合 p.Pro206Leu 或 p.Val263Gly 突变的患者,并比较了他们的临床表型。我们进行了 Kaplan-Meier 分析和对数秩检验,以评估步态障碍和无法独立行走的年龄。p.Pro206Leu 或 p.Val263Gly 突变患者的步态障碍累积发生率低于纯合 c.689_690insT 突变患者(P=0.001)。纯合 c.689_690insT 突变患者无法独立行走的累积发生率高于 p.Pro206Leu 或 p.Val263Gly 突变患者(P=0.004)。使用 Cox 比例风险模型,我们发现纯合 c.689_690insT 突变与步态障碍发病风险增加(调整后的危险比:6.60)和无法独立行走的风险增加(调整后的危险比:2.99)相关。所有纯合 c.689_690insT 突变的患者在<15 岁时均出现眼球运动性失用。大约一半的纯合 c.689_690insT 突变患者出现认知障碍。相比之下,在 p.Pro206Leu 或 p.Val263Gly 突变的患者中,只有约 50%的患者出现眼球运动性失用,且从未出现认知障碍。使用性别、年龄和 c.689_690insT 等位基因数作为独立变量的逐步多元回归分析表明,c.689_690insT 等位基因数与运动神经传导速度、尺神经运动神经传导速度和血清白蛋白值呈独立负相关。在患者 c.[689_690insT]+[840delT]、p.[Pro206Leu]+[Pro206Leu]和 p.[Pro206Leu]+[Val263Gly]突变中,用 aprataxin N 端抗体未检测到 aprataxin 蛋白。此外,Pro206Leu 和 Val263Gly aprataxin 蛋白不稳定。然而,c.689_690insT aprataxin 信使 RNA 的量也减少了,导致来自 c.689_690insT 等位基因的 aprataxin 蛋白量更显著减少。总之,纯合 c.689_690insT 突变的早发性共济失调伴眼球运动性失用和低白蛋白血症患者表现出比 p.Pro206Leu 或 p.Val263Gly 突变患者更严重的表型。